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The carbene derived from (1R,3S)-camphoric acid was used to prepare the borane adduct with Piers’ 
borane 7. Subsequent hydride abstraction gave the borenium cation 8. Adducts with 9-BBN and the 
corresponding (1R,3S)-camphoric acid-derived carbene bearing increasingly sterically demanding N-
substituents (R = Me 9, Et 10, i-Pr 11) and the corresponding borenium cations 12-14 were also prepared. 
These cations were not active as catalysts in hydrogenation, although 9-11 were shown to undergo carbene 
ring expansion reactions at 50 °C to give species 15-17. The IBOX-carbene precursors 18 and 19 derived from 
amino alcohols (S)-valinol and (S)-tert-leucinol (R = i-Pr, t-Bu) were used to prepare borane adducts 20-23. 
Reaction of the carbenes 1,3-dimethylimidazol-2-ylidene (IMe), 1,3-di-iso-propylimidazol-2-ylidene (IPr) 
diisopinocampheylborane 1-benzyl-3-methylimidazol-2-ylidene (IBnMe), 1-methyl-3-phenylimidazol-2-
ylidene (IPhMe) and 1-tert-butyl-3-methylimidazol-2-ylidene (ItBuMe) with (Ipc2BH) gave chiral adducts: 
(IMe)(Ipc2BH) 24, (IPr)(Ipc2BH) 25, (IBnMe)(Ipc2BH)  26, (IPhMe)(Ipc2BH) 27, and (ItBuMe)(Ipc2BH)  28. 
Triazolylidene-type adducts including  the (10)-phenyl-9-borabicyclo [3.3.2]decane adduct of 1,3,4-triphenyl-
1H-1,2,3-triazolium, rac-29 and the 9-BBN derivative of (S)-2-amino-2'-methoxy-1,1'-binaphthalene-1,2,3-
triazolium 34a/b were also prepared.  In catalytic studies of these systems, while several species were 
competent catalysts for imine reduction, in general, low enantioselectivities, ranging from 1-20% ee, were 
obtained. The implications for chiral borenium cation catalyst design are considered.  
 
 
Introduction  
Following the advent of the concept of “frustrated Lewis pairs” 
(FLPs) a decade ago,1-2 the initial application that emerged from the 
metal-free activation of H2 was the use of these in hydrogenation 
catalysis,3-7 resulting in a burgeoning and exciting area of new 
developments.8-13 The scope of substrates that can be reduced by 
an FLP protocol has broadened dramatically from the original 
application to imines, protected nitriles and aziridines.7 Indeed 
protocols for the reduction of enamines,14 silylenol-ethers,15 
alkenes,16-18 alkynes,19 ketones and aldehydes20-23 have emerged. 
These advances have been reviewed in several places.8-10, 13, 24-26  
Analogous to the development of homogeneous transition-
metal based catalysts, following the discovery of FLP catalysts, 
attention has turned to the development of stereoselective 
systems. The first to report such an advance was Klankermayer, 
who described the use of a chiral electrophilic borane derived from 
(+)-α-pinene in ketimine reduction affording 13% ee in the reduced 
amine product.27 Since then, other chiral catalyst systems have 
emerged (Figure 1). In some cases, stereoselectivity has climbed to 
give ee’s as high as 99%.28-32 These systems (Figure 1) all employ 
electron withdrawing pentafluorophenyl-groups to enhance the 
Lewis acidity at the boron center that enables H2 activation and 
catalytic turnover in imine reduction. Recently however, the 
chemistry of borocations has gained significant momentum.33 In 
these systems the tri-coordinate boron possesses a formal positive 
charge, enhancing the Lewis acidity at boron without the need for 
electron withdrawing fluorinated groups. Such systems have been 
employed in 1,n-carboboration,34 hydroboration,35 haloboration36 
and alkyne/arene borylation reactions.37 In addition, borenium 
cations have been found to act as the Lewis acid constituent of FLPs 
for catalytic hydrogenation.38-40 For example, borenium cations of 
the form [(L)BBN][B(C6F5)4] (L = N-heterocyclic carbene (NHC), BBN 
= 9-boreniumbicyclo[3.3.1]-nonane), were shown to be effective in 
the hydrogenation of imines and enamines.38-39 These catalysts 
offer the advantage of being readily derived from robust and easily 
prepared carbene adducts of 9-BBN. In a subsequent effort, we 
showed that these particular systems could be optimised for 
reactivity by modification of the carbene. Subsequently Crudden 
and Eisenberger employed related triazolium-borenium cations in 
hydrogenation catalysis.40  
       Imine reductions by borenium catalysts typically occur by 
delivery of hydride from the borane adduct to the iminium cation 
(Scheme 1).38-39 Thus, introducing chirality in the borane adduct 
provides potential for controlling stereochemistry in the products. 
The use of NHCs and triazolylidene derivatives as supporting 
ligands for borenium ions provides a straightforward approach to 
incorporate chirality through this ligand. In this manuscript, we 
describe the synthesis of chiral carbene adducts of borenium ions 
and preliminary evaluation of these systems in hydrogenation 
catalysis. 
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Figure 1 Selected chiral electrophilic boranes used in FLP hydrogenations. 
The highest enantioselectivities reported for each catalyst are shown.  
 
Scheme 1 Mechanism of borenium-based hydrogenation of imines.  
Experimental Section 
General Remarks Unless otherwise stated, all reactions and 
manipulations were performed under an atmosphere of dry, 
oxygen-free, nitrogen in a glove box (Innovative Technology or 
MBraun). All solvents (including deuterated) were dried and stored 
over molecular sieves under a nitrogen atmosphere before use. 1H, 
13C, 11B, 19F and 31P NMR data were recorded on a Bruker Avance III 
or Bruker 500 MHz spectrometer. All NMR spectra were recorded 
at 298 K unless otherwise stated and these data are reported in 
ppm. NMR assignments are further detailed in the SI. A Perkin-
Elmer analyser was used for carbon, hydrogen, and nitrogen 
elemental analysis. (3S,7S)-3,7-diisopropyl-2,3,7,8-tetrahydro-
imidazo[4,3-b:5,1-b’]-bis (oxazole)-4-ium triflate (18), and (3S,7S)-
3,7-di-tertbutyl-2,3,7,8-tetrahydroimidazo [4,3-b:5,1-
b']bis(oxazole)-4-ium triflate, [(3S,7S)-3,7-t-Bu2-2,3,7,8-
C7H7O2N2][O3SCF3] (19),
41-42 N-(1-phenylethylidene) aniline,43 (+)-
diisopinocampheylborane44 and 1,3-dimethylimidazolium iodide,45 
1-methyl-3-phenylimidazolium iodide,46 1-benzyl-3-
methylimidazolium iodide47 and (3S,7S)-3,7-di-isopropyl-2,3,7,8-
tetrahydroimidazo[4,3-b:5,1-b’]yilidene-9-
borabicyclo[3.3.1]nonane48 were prepared by literature 
procedures. In some cases repeated attempts to secure satisfactory 
elemental analyses lead to low C content, despite the use of 
additional oxidant, and is attributed to the formation of boron-
carbide during combustion.  
Synthesis of (1R,3S)-1,2,2-trimethylcyclopentane-1,3-diamine (2): 
To a solution of 18.94 g (1R,3S)-camphoric acid 1 (94.95 mmol, 
1.0 equiv.) and 50 mL of conc. sulfuric acid in 300 mL chloroform 
was added 17.99 g NaN3 (276.73 mmol, 2.9 equiv.) over a period of 
3 h. The reaction mixture was stirred at 55 °C for 18 h while gas 
evolution was observed. After cooling to 25 °C, 1 L of water was 
added and the aqueous phase was isolated. The aqueous phase 
was then made strongly basic by the addition of NaOH and the 
product was extracted with CH2Cl2 (3 x 500 mL). The combined 
organic layers were dried over MgSO4 and the solvent was removed 
in vacuo to provide the product 2 as a colourless solid. Yield: 7.77 g 
(54.62 mmol, 58%) 1H NMR (CDCl3): 0.77 (s, 3H), 0.79 (s, 3H), 1.00 
(s, 3H), 1.24-1.32 (m, 1H), 1.54-1.66 (m, 6H), 1.96-2.04 (m, 1H), 2.96 
(dd, 3JHH = 9 Hz, 
3
JHH = 7 Hz, 1H). 
13C{1H} NMR (CDCl3): 16.4, 22.3, 
26.0, 30.4, 38.5, 46.3, 60.9, 61.1. HRMS (ESI+): C8H19N2, [M+H
+] m/z 
(calc.): 143.1543, m/z (obs.): 143.1546. 
Synthesis of (1R,5S)-1,8,8-trimethyl-4-aza-2-azoniabicyclo[3.2.1]-
oct-2-ene tetrafluoroborate (3): A suspension of 2.00 g camphoric 
diamine 2 (14.06 mmol, 1 equiv.) and 1.62 g NH4BF4 (15.45 mmol, 
1.1 equiv.) in 15 mL triethylorthoformate (excess) was stirred at 
110 °C for 2 h. Upon cooling to 25 °C the precipitate was isolated 
by filtration and washed with Et2O (3 x 30 mL). Removal of the 
solvent in vacuo afforded the product 3 as a colourless solid. Yield: 
1.84 g (10.84 mmol, 77%). 1H NMR (CD3CN): 0.98 (s, 3H), 1.11 (s, 
3H), 1.22 (s, 3H), 2.02-2.17 (m, 3H), 2.29-2.35 (m, 1H), 3.42 (d, 3JHH 
= 5 Hz, 1H), 7.61 (s, 1H), 7.84 (bs, 2H). 13C{1H} NMR (CD3CN): 16.2, 
16.8, 20.6, 34.0, 39.5, 42.7, 62.5, 66.6, 152.4. HRMS (ESI+): C9H17N2, 
[M+] m/z (calc.): 153.1386, m/z (obs.): 153.1388. 
Synthesis of (1R,5S)-1,2,4,8,8-pentamethyl-4-aza-2-diazoniabi-
cyclo[3.2.1]oct-2-ene tetrafluoroborate (4), (1R,5S)-2,4-diethyl-
1,8,8-trimethyl-4-aza-2-azoniabicyclo[3.2.1]oct-2-ene tetrafluoro-
borate (5), (1R,5S)-2,4-diisopropyl-1,8,8-trimethyl-4-aza-2-azonia-
bicyclo[3.2.1]oct-2-ene tetrafluoroborate (6): These compounds 
were prepared in a similar fashion from the corresponding 
iodoalkane and thus one preparation is detailed. 1.31 mL 
iodomethane (20.83 mmol, 5 equiv.) were added to a suspension of 
1.00 g diamine 3 (4.17 mmol, 1 equiv.) and 1.44 g K2CO3 
(10.41 mmol, 2.5 equiv.) in MeCN (25 mL). The reaction mixture 
was stirred under reflux for 44 h. Upon cooling to 25 °C the solvent 
and remaining iodomethane were removed in vacuo. The residual 
solid was dissolved in CH2Cl2 and then filtered. The resulting filtrate 
was concentrated under reduced pressure to give the product 4a as 
a white solid. Yield: 0.98 g (4.07 mmol, 86%). 1H NMR (CDCl3): 1.08 
(s, 3H), 1.13 (s, 3H), 1.27 (s, 3H), 1.87-1.93 (m, 1H), 2.05-2.13 (m, 
1H), 2.31-2.37 (m, 1H), 2.53-2.59 (m, 1H), 3.12 (d, 3JHH = 5 Hz, 1H), 
3.24 (s, 3H), 3.32 (s, 3H), 9.02 (s, 1H). 13C{1H} NMR (CDCl3): 14.2, 
16.9, 21.8, 30.6, 37.0, 38.5, 40.8, 41.1, 68.8, 69.5, 153.7. 
HRMS (ESI+): C11H21N2, [M
+] m/z (calc.): 181.1699, m/z (obs.): 
181.1701. 
5: Yield: 0.89 g (3.00 mmol, 96%). 1H NMR (CDCl3): 1.03 (s, 3H), 1.15 
(s, 3H), 1.30 (t, 3JHH = 7 Hz, 3H), 1.34 (s, 3H), 1.38 (t, 
3
JHH = 7 Hz, 3H), 
1.94-2.01 (m, 1H), 2.10-2.17 (m, 1H), 2.26-2.31 (m, 1H), 2.49-2.55 
(m, 1H), 3.19 (d, 3JHH = 5 Hz, 1H), 3.52-3.60 (m, 1H), 3.62-3.69 (m, 
1H), 3.70-3.77 (m, 1H), 3.79-3.86 (m, 1H), 9.05 (s, 1H). 13C{1H} NMR 
(CDCl3): 14.1, 14.3, 17.2, 17.3, 21.9, 32.1, 40.6, 40.8, 45.3, 48.7, 
66.3, 69.9, 153.2. HRMS (ESI+): C13H25N2, [M
+] m/z (calc.): 209.2012, 
m/z (obs.): 209.2018. 
6: Yield: 2.46 g (6.43 mmol, 96%). 1H NMR (CDCl3): 0.90 (s, 3H), 1.12 
(s, 3H), 1.20 (d, 3JHH = 6.7 Hz, 3H), 1.27 (d, 
3
JHH = 7 Hz, 3H), 1.32 (s, 
3H), 1.36 (d, 3JHH = 7 Hz, 3H), 1.47 (d, 
3
JHH = 7 Hz, 3H), 1.92-1.98 (m, 
1H), 2.04-2.09 (m, 1H), 2.13-2.20 (m, 1H), 2.36-2.42 (m, 1H), 3.28 
(d, 3JHH = 5 Hz, 1H), 3.85 (sept, 
3
JHH = 7 Hz, 1H), 4.31-4.39 (m, 1H), 
8.13 (s, 1H). 13C{1H} NMR (CDCl3): 14.9, 17.7, 20.7, 21.7, 22.2, 23.6, 
25.1, 33.4, 40.4, 41.1, 51.1, 55.9, 61.4, 71.5, 151.1. HRMS (ESI+): 
C15H29N2, [M
+] m/z (calc.): 237.2325, m/z (obs.): 237.2330. 
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Synthesis of (1R,5S)-1,2,4,8,8-pentamethyl-2,4-diazobicyclo-
[3.2.1]oct-3-ylidene-bis(pentafluorophenyl)borane (7): A 
suspension of 107 mg of 4 (0.40 mmol, 1 equiv.) and 80 mg 
K[N(SiMe3)2] (0.40 mmol, 1 equiv.) in 2 mL THF were stirred at r.t. 
for 60 h. After filtration over Celite and removal of the solvent in 
vacuo, the free carbene was redissolved 2 mL toluene. A solution of 
138 mg of Piers borane (0.4 mmol, 1 equiv.) in 1 mL toluene was 
added. The reaction mixture was stirred at 25 °C for 2 h. The 
volatiles were removed in vacuo and the product was extracted 
with toluene to give the pure product 5d as an orange solid. Yield: 
127 mg (0.24 mmol, 60%). 1H NMR (CD2Cl2): 0.88 (s, 3H), 0.89 (s, 
3H), 0.98 (s, 3H,), 1.59-1.68 (m, 1H), 1.84-1.90 (m, 1H), 2.20-2.27 
(m, 1H), 2.64 (s, 3H), 1.75 (d, 3JHH = 5 Hz, 1H), 2.88 (s, 3H). 
11B NMR 
(CD2Cl2): -23.4 (d, 
1
JBH = 91 Hz). 
13C{1H} NMR (CD2Cl2): 15.5, 16.8, 
22.8, 29.6, 36.4, 36.9, 39.3, 41.6, 42.3, 70.7, 71.5, 136.3, 138.2, 
140.2, 147.5, 149.4, 153.6. 19F NMR (CD2Cl2): -133.3 (d, 
3
JFF = 22 Hz), 
-134.7 (d, 3JFF = 22 Hz), -161.57 (t, 
3
JFF = 20 Hz), -161.63 (t, 
3
JFF = 
20 Hz), -165.49 to -165.72 (m). HRMS (ESI+): C23H20BF10N2, [M
+] m/z 
(calc.): 524.1591, m/z (obs.): 524.1593. Anal. Calcd. for 
C23H20BF10N2: C 52.50, H 4.02, N 5.32%; Obs. C 53.24, H 3.33, N 
5.11%. 
Synthesis of (1R,5S)-1,2,4,8,8-pentamethyl-2,4-diazobicyclo-
[3.2.1]oct-3-ylidene-bis(pentafluorophenyl)borenium 
tetrakis(pentafluorophenyl)borate (8): A solution of 287 mg 
(0.31 mmol, 1 equiv.) trityl tetrakis(pentafluorophenyl)borate 
(0.31 mmol, 1 equiv.) in toluene was added dropwise to a solution 
of 95 mg borane-adduct 7 (0.31 mmol, 1 equiv.) in toluene at -
40 °C. The reaction mixture was then allowed to warm slowly to 
25 °C and was stirred for 18 h, while an insoluble oil was formed. 
The solvent was evaporated in vacuo and the crude product 
washed with pentane (3 x 3 mL) to afford the desired product 6a as 
a white solid. Yield: 252 mg (0.26 mmol, 83%). 1H NMR (CD2Cl2): 
1.10 (s, 3H), 1.15 (s, 3H), 1.34 (s, 3H), 1.63-1.72 (bm, 3H), 1.83-1.87 
(bm, 1H), 1.94-2.07 (bm, 6H), 2.15-2.23 (m, 3H), 2.23-2.31 (bm, 5H), 
2.37-2.44 (m, 1H), 2.93 (s, 3H), 3.05 (s, 3H), 3.15 (d, 3JHH = 5 Hz, 1H). 
11B NMR (CD2Cl2): -16.8 (s), 89.1 (bs). 
13C{1H} NMR (CD2Cl2): 14.4, 
17.0, 21.8, 22.9, 30.7, 30.8, 31.2, 32.4 (bs), 33.2 (bs), 36.5, 36.7, 
37.4, 38.0, 38.9, 41.0, 42.3, 71.1, 71.2, 124.0 (bs), 124.9 (bs), 136.4 
(d, 1JFC = 243 Hz), 138.8 (d, 
1
JFC = 246 Hz), 148.7 (d, 
1
JFC = 241 Hz), 
173.2. 19F NMR (CD2Cl2): -133.1 (bs), -163.7 (m), -167.6 (bs). HRMS 
(ESI+): C19H35BN2, [M+H
+] m/z (calc.): 302.3002, m/z (obs.): 
302.2999. 
Synthesis of (1R,5S)-1,2,4,8,8-pentamethyl-4-aza-2-diazoniabi-
cyclo[3.2.1]oct-3-ylidene-(9-borabicyclo[3.3.1]-nonane) (9), 
(1R,5S)-2,4-diethyl-1,8,8-trimethyl-4-aza-2-azoniabicyclo[3.2.1]-
oct-3-ylidene-(9-borabicyclo[3.3.1]-nonane) (10), (1R,5S)-2,4-
diisopropyl-1,8,8-trimethyl-4-aza-2-azoniabicyclo[3.2.1]oct-3-ylid-
ene-(9-borabicyclo[3.3.1]-nonane) (11): These compounds were 
prepared in a similar fashion and thus one preparation is detailed. 
107 mg of the carbene precursor 4 (0.40 mmol, 1 equiv.) and 80 mg 
of K[N(SiMe3)2] (0.40 mmol, 1 equiv.) were suspended in 2 mL of 
THF and stirred at 25 °C for 20 min. The reaction mixture was 
filtered through celite and the volatiles were removed in vacuo to 
give the free carbene. The carbene was redissolved in 2 mL toluene 
and added to a suspension of 48 mg of 9-BBN dimer (0.20 mmol, 
0.5 equiv.) in 2 mL of toluene. The mixture was stirred for 30 min 
and the solvent was removed under reduced pressure. The residue 
was extracted with pentane (4 x 2 mL), which was subsequently 
removed in vacuo to provide the product 9 as a white solid. Yield: 
98 mg (0.32 mmol, 81%). 1H NMR (benzene-d6): 0.36 (s, 3H), 0.58 
(s, 3H), 0.74 (s, 3H), 0.97-1.05 (m, 1H), 1.15-1.32 (m, 3H), 1.51 (bs, 
1H), 1.56-1.69 (m, 4H), 1.95-2.01 (m, 3H), 2.05-2.19 (m, 3H), 2.21-
2.30 (m, 2H), 2.37-2.57 (m, 3H), 3.04 (s, 6H). 11B NMR (benzene-d6): 
-14.2 (d, 1JBH = 83 Hz). 
13C{1H} NMR (benzene-d6): 15.4, 17.0, 22.2, 
23.2, 25.5, 28.7, 31.0, 31.4, 34.6, 35.6, 38.8, 39.0, 40.5, 41.5, 69.0, 
70.2.1. HRMS(ES+): C19H36BN2, [M
+] m/z (calc.): 302.3008, m/z 
(obs.): 302.3009. 
10: Yield: 220 mg (0.67 mmol, 67%), 1H NMR (benzene-d6): 0.43 (s, 
3H), 0.69 (s, 3H), 0.74 (s, 3 H), 0.94 (t, 3JHH = 7 Hz, 3H), 1.05 (t, 
3
JHH = 
7 Hz, 3H), 1.22 (m, 2H), 1.35 (m, 1H), 1.49 (m, 3H), 1.67 (m, 1H), 
1.93 (m, 1H), 2.09 (m, 6H), 2.27 (m, 3H), 2.41 (m, 1H), 2.54 (m, 2H), 
3.14 (m, 1H), 3.60 (sept, 3JHH = 7 Hz, 1H), 3.67 (sept, 
3
JHH = 7 Hz, 1H), 
4.30-4.39 (m, 1H). 11B NMR (benzene-d6): -14.3 (d, 
1
JBH = 84 Hz). 
13C{]H} NMR (benzene-d6): 18.1, 18.3, 20.3, 20.9, 21.7, 22.6, 24.6, 
25.4, 25.8, 30.8, 32.1, 32.8, 37.7, 39.7, 40.5, 40.6, 49.9, 52.8, 59.8, 
69.7.2. HRMS (ESI+): C21H40BN2, [M
+] m/z (calc.): 330.3321, m/z 
(obs.): 330.3325. Anal. Calcd. for C21H40BN2: C 76.35, H 11.40, N 
8.48%; Obs. C 76.53, H 10.57, N 8.00%. 
11: Yield: 227 mg (0.63 mmol, 63%). 1H NMR (benzene-d6): 0.45 (s, 
3H), 0.66 (s, 3H), 0.93-0.97 (m, 9H), 1.15 (d, 3JHH = 7.2 Hz, 3H), 1.24 
(d, 3JHH = 7.2 Hz, 3H), 1.27 (bs, 2H), 1.41 (bs, 1H), 1.45-1.52 (bm, 
2H), 1.93-2.04 (bm, 3H), 2.09-2.71 (m, 12H), 5.47 (sept, 3JHH = 7 Hz, 
1H), 5.56 (sept, 3JHH = 7 Hz, 1H). 
11B NMR (benzene-d6): -12.9 (d, 
1
JBH 
= 85 Hz). 13C{1H} NMR (benzene-d6): 18.2, 18.5, 20.5, 21.0, 21.9, 
22.7, 24.8, 25.0 (bs), 25.6, 26.0, 27.1 (bs), 30.9, 32.3, 33.0, 37.8, 
39.9, 40.7, 40.8, 50.1, 52.9, 59.9, 69. 8.3. HRMS(ESI+): C23H44BN2, 
[M+] m/z (calc.): 358.3634, m/z (obs.): 358.3624. Anal. Calcd. for 
C23H44BN2: C 77.08, H 12.09, N 7.82%; Obs. C 76.76, H 12.91, N 
7.76%. 
Synthesis of (1R,5S)-1,2,4,8,8-pentamethyl-4-aza-2-diazoniabi-
cyclo[3.2.1]oct-3-ylidene-(9-boreniumbicyclo[3.3.1]-nonane) 
tetrakis(pentafluorophenyl)borate (12), (1R,5S)-2,4-diethyl-1,8,8-
trimethyl-4-aza-2-azoniabicyclo[3.2.1]oct-3-ylidene-(9-borenium-
bicyclo[3.3.1]-nonane) tetrakis(pentafluorophenyl)borate (13), 
(1R,5S)-2,4-diisopropyl-1,8,8-trimethyl-4-aza-2-azoniabicycle-
[3.2.1]oct-3-ylidene-(9-boreniumbicyclo[3.3.1]-nonane) tetrakis-
(pentafluorophenyl)borate (14): These compounds were prepared 
in a similar fashion and thus one preparation is detailed. A solution 
of 287 mg (0.31 mmol, 1 equiv.) trityl tetrakis-
(pentafluorophenyl)borate (0.31 mmol, 1 equiv.) in toluene was 
added dropwise to a solution of 95 mg borane-adduct 9 
(0.31 mmol, 1 equiv.) at -40 °C. The reaction mixture was then 
allowed to warm slowly to 25 °C and was stirred for 18 h, while an 
insoluble oil was formed. The solvent was evaporated in vacuo and 
the crude product washed with pentane (3 x 3 mL) to afford the 
desired product 12 as a white solid. Yield: 252 mg (0.26 mmol, 
83%). 1H NMR (CD2Cl2): 1.10 (s, 3H), 1.15 (s, 3H), 1.34 (s, 3H), 1.63-
1.72 (bm, 3H), 1.83-1.87 (bm, 1H), 1.94-2.07 (bm, 6H), 2.15-2.23 
(m, 3H), 2.23-2.31 (bm, 5H), 2.37-2.44 (m, 1H), 2.93 (s, 3H), 3.05 (s, 
3H), 3.15 (d, 3JHH = 5 Hz, 1H). 
11B NMR (CD2Cl2): -16.8 (s), 89.1 (bs). 
13C{1H} NMR (CD2Cl2): 14.4, 17.0, 21.8, 22.9, 30.7, 30.8, 31.2, 32.4 
(bs), 33.2 (bs), 36.5, 36.7, 37.4, 38.0, 38.9, 41.0, 42.3, 71.1, 71.2, 
124.0 (bs), 124.9 (bs), 136.4 (d, 1JFC = 243 Hz), 138.8 (d, 
1
JFC = 
246 Hz), 148.7 (d, 1JFC = 241 Hz), 173.2. 
19F NMR (CD2Cl2): 133.1 (bs), 
-163.7 (m), -167.6 (bs). HRMS(ESI+): C19H35BN2, [M+H
+] m/z (calc.): 
302.3002, m/z (obs.): 302.2999. 
13: Yield: 299 mg (0.29 mmol, 98%). 1H NMR (CD2Cl2): 1.05(s, 3H), 
1.16 (s, 3H), 1.27 (t, 3J = 7.1 Hz, 3H), 1.37 (t, 3J = 7.1 Hz, 3H), 1.41 
(s, 3H), 1.64-1.70 (m, 3H), 1.81 (s, br, 1H), 1.89-2.02 (m, 6H), 2.07-
2.12 (m, 1H), 2.14-2.18 (m, 1H), 2.21-2.25 (m, 1H), 2.27-2.37 (m, 
5H), 2.42-2.47 (m, 1H), 2.75 (dq, 3JHH = 7 Hz, 
2
JHH = 16 Hz, 1H), 3.09 
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(dq, 3JHH = 7 Hz, 
2
JHH = 14.5 Hz, 1H), 3.22-3.29 (m, 2H), 3.53 (dq, 
3
JHH = 7 Hz, 
2
JHH = 16 Hz, 1H). 
11B NMR (CD2Cl2): -16.7 (s), 89.1 (bs). 
13C{1H} NMR (CD2Cl2): 13.3, 13.3, 16.3, 16.7, 20.4, 21.8, 22.0, 30.9 
(bs), 31.2 (bs), 31.5, 35.7, 36.0, 36.3, 36.4, 39.5, 40.0, 46.4, 48.6, 
66.2, 69.4, 136.5 (d, 1JCF = 237 Hz), 138.2 (d, 
1
JFC = 240 Hz), 148.4 (d, 
1
JFC = 238 Hz) 171.3.4. 
19F NMR (CD2Cl2): -133.1 (bs), -163.7 (t, 
3
JFF = 
20 Hz), -167.6 (t, 3JFF = 18 Hz). HRMS(ESI+): C21H38BN2, [M
+] m/z 
(calc.): 329.3123, m/z (obs.): 329.2739. Anal. Calcd. for C21H38BN2: C 
53.60, H 3.80, N 2.78%; Obs. C 54.21, H 2.60, N 2.50%. 
14: Yield: 276 mg (0.26 mmol, 93 %). 1H NMR (CD2Cl2): 1.09 (s, 3H), 
1.15 (s, 3H), 1.26 (d, 3JHH = 6.5 Hz, 3H), 1.34 (d, 
3
JHH = 6.5 Hz, 3H), 
1.46 (d, 3JHH = 6.8 Hz, 3H), 1.53 (s, 3H), 1.61 (d, 
3
JHH = 6.8 Hz, 3H), 
1.64-1.70 (m, 1H), 1.78-1.81 (bm, 1H), 1.81-1.85 (bm, 2H), 1.87-
1.89 (bm, 1H), 1.90-1.94 (bm, 2H), 2.03-2.13 (m, 3H), 2.23-2.39 
(bm, 7H), 2.55-2.61 (m, 1H), 2.68 (sept, 3JHH = 6.8 Hz, 1H), 3.10 
(sept, 3JHH = 7 Hz, 1H), 3.32 (d, 
3
JHH = 5 Hz, 1H). 
11B NMR (CD2Cl2): -
16.7 (s), 85.8 (bs). 13C NMR (CD2Cl2): 13.9, 16.2, 16.8, 19.3, 19.7, 
20.3, 21.3, 21.6, 21.8, 29.2, 29.4, 33.0, 35.5, 35.7, 36.4, 36.5, 39.7, 
40.6, 55.9, 59.8, 61.0, 71.4, 136.1 (d, 1JCF = 242 Hz), 138.0 (d, 
1
JCF = 
240 Hz), 148.2 (d, 1JCF = 241 Hz), 171.6.5. 
19F NMR (CD2Cl2): -133.1 
(bs), -163.8 (t, 3JFF = 21 Hz), -167.6 (t, 
3
JFF = 18 Hz). HRMS (ESI+): 
C23H42BN2, [M
+] m/z (calc.): 356.3472, m/z (obs.): 356.3477. 
Synthesis of (1S,4R,6R)-2,5-dialkyl-6,9,9-trimethyl-2,5-diaza-3-
borabicyclo[4.2.1]nonanes (alkyl = Me: 15, Et: 16, iPr: 17): These 
compounds were prepared in a similar fashion and thus one 
preparation is detailed. 50 mg of the borane adduct 12 (0.17 mmol) 
were dissolved in 4 mL pentane and heated to 50-110 °C for 4-16 h. 
The solvent was then removed in vacuo to provide the pure 
product 15 in quantitative yield as a white solid. Yield: 50 mg 
(0.17 mmol, >99%). 1H NMR (benzene-d6): 0.78 (s, 3H), 0.97 (s, 3H), 
1.15 (s, 3H), 1.35-1.42 (m, 1H), 1.53-1.60 (m, 4H), 1.63-1.95 (m, 
13H), 2.09-2.25 (m, 3H), 2.38 (bs, 1H), 2.53 (bs, 1H), 2.59 (s, 3H), 
2.62 (d, 3JHH = 5 Hz, 1H), 2.64 (s, 3H). 
11B NMR (benzene-d6): 44.2 
(bs). 13C{1H} NMR (benzene-d6): 5.0, 16.6, 20.6, 21.8, 22.7, 24.9 (bs), 
25.6, 28.4, 30.5, 30.8, 34.2, 35.2, 38.3, 38.5, 40.1, 41.0, 44.5, 67.6, 
68.7 (bs), 69.8, 79.2. HRMS(ESI+): C19H36BN2, [M
+] m/z (calc.): 
302.3002, m/z (obs.): 302.3003. 
16: Yield: 20 mg (0.06 mmol, >99%). 1H NMR (benzene-d6): 0.81 (s, 
3H), 0.85 (s, 3H), 0.92 (t, 3JHH = 7 Hz, 3H), 1.20 (t, 
3
JHH = 7 Hz, 3H), 
1.22 (s, 3H), 1.36-1.43 (m, 1H), 1.53-2.01 (m, 15H), 2.12-2.24 (m, 
2H), 2.43-2.58 (m, 3H), 2.64 (d, 3JHH = 5 Hz, 1H), 2.69 (s, 1H), 3.20-
3.35 (m, 2H). 11B NMR (benzene-d6): 44.0 (bs). 
13C{1H} NMR 
(benzene-d6): 14.3, 15.7, 17.1, 18.2, 21.7, 29.8, 30.6, 30.8, 31.0, 
31.5, 37.6, 38.8, 39.0, 39.3, 41.8, 42.5, 46.9, 47.3, 50.4, 51.9, 66.3, 
76.2. HRMS (ESI+): C21H38BN2, [M
+] m/z (calc.): 328.3164, m/z 
(obs.): 328.3175. Anal. Calcd. for C21H38BN2: C 76.35, H 11.90, N 
8.48%; Obs. C 76.57, H 11.63, N 8.09%. 
17: Yield: 45 mg (0.13 mmol, >99%). 1H NMR (benzene-d6): 0.74 (s, 
3H), 0.85 (s, 3H), 0.86 (d, 3JHH =7 Hz, 3H), 1.00 (d, 
3
JHH = 7 Hz, 3H), 
1.22 (d, 3JHH = 7 Hz, 6H), 1.25 (s, 3H), 1.49-1.55 (m, 2H), 1.71-1.81 
(m, 6H), 1.86-1.97 (m, 6H), 2.23-2.32 (m, 3H), 2.94 (d, 3JHH = 6 Hz, 
1H), 3.31 (s, 1H), 3.49 (sept, 3JHH = 7 Hz, 1H), 3.93 (sept, 
3
JHH = 7 Hz, 
1H). 11B NMR (benzene-d6): 44.0 (bs). 
13C{1H} NMR (benzene-d6): 
20.7, 21.3, 21.9, 22.1, 23.8, 25.0 (bs), 25.4, 27.1, 28.2, 29.0, 31.3, 
32.2, 33.2, 33.4, 42.0, 47.2, 48.1, 48.6, 49.6, 54.6 (bs), 66.9, 70.0. 
HRMS (ESI+): C23H42BN2, [M
+] m/z (calc.): 356.3477, (obs.): 
356.3484. Anal. Calcd. for C23H42BN2: C 77.08, H 12.04, N 7.82%; 
Obs. C 77.10, H 12.36, N 7.75%. 
Synthesis of (3S,7S)-3,7-di-isopropyl-2,3,7,8-tetrahydroimidazo-
[4,3-b:5,1-b']bis[1,3]oxazol-4-ylidene-(9-borabicyclo[3.3.1]-no-
nane) (20), (3S,7S)-3,7-di-isopropyl-2,3,7,8-tetrahydroimidazo[4,3-
b:5,1-b']bis[1,3]oxazol-4-ylidene-borane (21), (3S,7S)-3,7-di-
isopropyl-2,3,7,8-tetrahydroimidazo[4,3-b:5,1-b']bis[1,3]oxazol-4-
ylidene-(dicyclohexylchloroborane) (22), (3S,7S)-3,7-di-tertbutyl-
2,3,7,8-tetrahydroimidazo[4,3-b:5,1-b']bis[1,3]oxazol-4-ylidene-
(9-borabicyclo[3.3.1]-nonane) (23): These compounds were 
prepared in a similar fashion and thus one preparation is detailed. 
Triflate salt 18 (110 mg, 0.285 mmol) and 9-BBN dimer (35 mg, 
0.1425 mmol) were dissolved in 2.5 mL THF at -35 °C. K[N(SiMe3)2 
(58 mg, 0.29 mmol) were dissolved in 2 mL THF at -35 °C and the 
solution was added dropwise to the mixture. The mixture was 
stirred overnight at room temperature and the volatiles were 
removed in vacuo. The residue was extracted with pentane, filtered 
through Celite, and dried to a light yellow powder. Crystals for a 
single crystal X-ray study were obtained by slow evaporation of 
pentane. Yield: 20 (60 mg, 0.167 mmol, 58%) 1H NMR (benzene-d6): 
4.10 (ddd, 3JHH = 7 Hz, 
4
JHH = 3 Hz, 
2
JHH = 1 Hz, 2H), 3.92 (dd, 
3
JHH = 9 
Hz, 3JHH = 1 Hz, 2H), 3.72 (ddd, 
4
JHH = 9 Hz, 
3
JHH = 7 Hz, 
2
JHH = 1 Hz, 
2H), 2.77-1.87 (m, 15H), 1.52-1.41 (m, 2H), 0.63 (d, 3JHH = 7 Hz, 6H), 
0.44 (d, 3JHH = 7.0 Hz, 6H). 
11B NMR (benzene-d6): -16.9 (d, 
1
JBH = 83 
Hz). 13C NMR (benzene-d6): 124.0, 75.7, 62.3, 37.0, 36.6, 33.6, 30.0, 
26.5, 26.0, 18.6, 14.6. MS (DART) m/z: 357 [M-H]+. HRMS (ESI+): 
[M+] m/z (calc.): C21H34BN2O2 357.2713 (obs): 357.2724. Anal. Calc. 
for C21H35BN2O2: C 70.39, H 9.85, N 7.82%. Found: C 69.30, H 9.34, 
N 7.42% 
21: Crystals for a single crystal X-ray study were obtained by slow 
evaporation from toluene. Yield: (44 mg, 0.176 mmol, 62%). 
1H NMR (benzene-d6): 4.06-3.91 (m, 4H), 3.86-3.74 (m, 2H), 2.89 
(ddq, 3JHH = 10 Hz, 
4
JHH = 7 Hz, 
3
JHH = 4 Hz, 2H), 2.40-1.65 (m, 1H), 
0.65 (d, 3JHH = 7 Hz, 6H), 0.44 (d, 
3
JHH = 7 Hz, 6H). 
11B NMR (benzene-
d6): -35.6 (q, 
1
JBH = 88 Hz). 
13C NMR (benzene-d6): 76.1, 61.1, 29.0, 
22.7, 18.3, 14.3. MS (DART) m/z: 249 [M-H]+. HRMS (ESI): (calc.). for 
C13H22BN2O2 249.1774, (obs): 249.1771. Anal. Calc. for C13H23BN2O2: 
C 62.42, H 9.27, N 11.20%. Found: C 62.02, H 9.27, N 11.10%. 
22: Crystals for a single crystal X-ray study were obtained by slow 
evaporation of toluene. Yield: (50 mg, 0.111 mmol, 35%). 1H  NMR 
(benzene-d6): 4.56 (dd, 
3
JHH = 7 Hz, 
2
JHH = 2 Hz, 2H), 3.91 (dd, 
3
JHH = 9 
Hz, 3JHH = 1 Hz, 2H), 3.71 (ddd, 
4
JHH = 9 Hz, 
3
JHH = 7 Hz, 
2
JHH = 1 Hz, 
2H), 3.02 (dtd, 3JHH = 14 Hz, 
3
JHH = 7 Hz, 
4
JHH = 3 Hz, 2H), 2.39 (bs, 
1H), 2.36 (bs, 1H), 2.09-0.95 (m, 18H), 0.68 (d, 3JHH = 7 Hz, 6H), 0.55 
(d, 3JHH = 7 Hz, 6H). 
11B NMR (benzene-d6): 3.2 (bs). 
13C NMR 
(benzene-d6): 75.9, 64.5, 32.8, 32.4, 31.4, 31.2, 31.1, 30.2, 29.7, 
29.6, 29.5, 28.4, 28.3, 28.2, 28.0, 18.7, 14.4. MS (DART) m/z: 413 
[M-Cl]+. HRMS (ESI): calc. for C25H42BN2O2 413.33393, found 
413.33381.  
23: Crystals for a single crystal X-ray study were obtained by slow 
evaporation of pentane. Yield: (88 mg, 0.228 mmol, 80%). 1H NMR 
(benzene-d6): 4.15 (d, 
3JHH  = 5 Hz, 2H), 4.04 (d, 
3JHH  = 9 Hz, 2H), 
3.78 (dd, 3JHH = 9 Hz, 
3JHH = 6 Hz, 2H), 2.82-1.74 (m, 14H), 1.55 (bs, 
1H), 1.16 (bs, 1H), 0.88 (s, 18H). 11B NMR (benzene-d6): -16.4 (d, 
1JBH = 86 Hz), 
13C NMR (benzene-d6): 124.3, 78.6, 68.3, 39.4, 35.3, 
33.1, 32.4, 27.5, 26.6, 25.9. MS (ESI+) m/z: 385 [M-H]+. HRMS (ESI): 
(calc.) for C23H38BN2O2+ 385.3026, (obs): 386.3032. Anal. Calc. for 
C23H39BN2O2: C 71.50, H 10.17, N 7.25%. Found: C 70.45, H 10.16, N 
6.79% 
Synthesis of  1,3-dimethylimidazol-2-ylidene-di-(1S,2R,3S,5S)-
isopinocampheylborane (24), 1,3-diisopropylimidazol-2-ylidene-
di-(1S,2R,3S,5S)-isopinocampheylborane (25), 1-benzyl-3-
methylimidazol-2-ylidene-di-(1S,2R,3S,5S)-isopinocampheylbor-
ane (26), 1-methyl-3-phenylimidazol-2-ylidene-di-(1S,2R,3S,5S)-
isopinocampheylborane (27), 1-tert-butyl-3-methylimidazol-2-
ylidene-di-(1S,2R,3S,5S)-isopinocampheylborane (28): These 
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compounds were prepared in a similar fashion and thus one 
preparation is detailed. In a glovebox, (+)-diisopinocampheylborane 
(396 mg, 1.38 mmol, 1 equiv.), K[N(SiMe3)2] (290 mg, 1.45 mmol, 
1.05 equiv.) and 1,3-dimethylimidazolium iodide (310 mg, 
1.34 mmol, 1 equiv.) were weighed into a flame-dried nitrogen-
cooled Schlenk flask. A magnetic stir bar was added and the flask 
was sealed with a rubber septum. The flask was removed from the 
glovebox and connected to a Schlenk line where it was stirred 
under nitrogen. Dry THF (20 mL) was added via cannula and the 
solution was stirred for 20 h at 25 °C. The solvent was removed in 
vacuo and the flask was reintroduced to the glovebox. The white 
residue was washed with pentane (3 x 2 mL). These washings were 
filtered through a plug of Celite and the residue washed with 
toluene (3 x 2 mL). The washings were filtered through the same 
Celite plug into a separate vial. The vials was capped and put in a 
freezer (-35 °C) where colourless crystals formed. The crystals were 
washed with cold pentane (3 x 1 mL) and dried in vacuo to give 24 
(198 mg, 37% yield). 1H NMR (CDCl3): 6.81 (s, 1H), 6.74 (s, 1H), 3.88 
(br, 6H), 2.18 (m, 1H), 2.13-2.07 (m, 2H), 2.05-1.96 (m, 1H), 1.92-
1.83 (m, 2H), 1.75-1.63 (m, 3H), 1.59-1.52 (m, 1H), 1.43-1.34 (m, 
1H), 1.32-1.23 (m, 1H), 1.19-1.02 (m, 2H), 1.122 (s, 3H) 1.117 (s, 
3H), 1.09 (overlapping s, 6H), 1.08 (d, 3JHH = 7 Hz, 3H), 0.95 (bd, 
3
JHH 
= 9 Hz, 2H), 0.71 (bd, 3JHH = 9 Hz, 2H), 0.59 (d, 
3
JHH = 7 Hz, 3H), (No 
B-H peak found). 11B NMR (toluene-d8): –9.1 (d, 
1
JBH = 86 Hz). 
13C{1H} NMR (CDCl3) partial: 121.1, 120.0, 50.8, 49.9, 45.0, 43.4, 
43.1, 42.7, 39.3, 39.1, 37.8, 37.5, 36.2, 35.3, 33.6, 33.3, 28.7, 28.5, 
23.8, 23.4, 23.13, 23.11. HRMS-EI (m/z): [M-H]+ calc. for C25H42BN2: 
381.34410, found: 381.34507.  
25: Yield: (198 mg, 34%). 1H NMR (CDCl3): 6.97 (d, 
3
JHH = 2 Hz, 1H), 
6.92 (d, 3JHH = 2 Hz, 1H), 5.84 (septet, 
3
JHH = 7 Hz, 1H), 5.13 (septet, 
3
JHH = 7 Hz,1H), 2.25 (m, 1H), 2.19-2.04 (m, 4H), 1.85, (m, 1H), 1.75-
1.67 (m, 2H), 1.65-1.54 (m, 3H), 1.46 (d, 3JHH = 7 Hz, 3H), 1.459 (d, 
3
JHH = 7 Hz, 3H), 1.459 (d, 
3
JHH = 7 Hz, 3H), 1.37 (d, 
3
JHH = 7 Hz, 3H), 
1.36 (d, 3JHH = 7 Hz, 3H), 1.12 (s, 3H), 1.11(s, 3H), 1.10 (d, 
3
JHH = 7 Hz, 
3H), 1.08 (s, 3H), 1.06 (s, 3H), 0.95 (d, 3JHH = 9 Hz, 1H), 0.84 (d, 
3
JHH = 
9 Hz, 1H) 0.48 (d, 3JHH = 7 Hz, 3H). 
11B NMR (toluene-d8): –8.2 (d, 
1
JBH = 86 Hz). 
13C{1H} NMR (CDCl3, partial): 115.8, 115.4, 50.6, 49.9, 
49.3, 48.9, 44.9, 43.3, 43.1, 42.1, 39.0, 38.9, 37.1, 35.4, 33.8, 32.7, 
28.38, 28.36, 24.10, 24.08, 23.82, 23.70, 23.38, 23.33, 23.03, 22.9. 
Anal. Calc. for C29H51BN2: C 79.43, H 11.72, N 6.39%. Found: C 
79.30, H 11.90, N 6.39%. 
26: Yield: (667 mg, 83% yield). 1H NMR (CD2Cl2): 7.42-7.21 (bm, 5H), 
6.88 (bs, 1H, minor), 6.80(bs, 1H, major), 6.76 (bs, 1H, major), 6.66 
(bs, 1H, minor), 5.74 (d, 2JHH = 15 Hz, 1H, minor), 5.66 (d, 
2
JHH = 15 
Hz 1H, major), 5.57 (d, 2JHH = 15 Hz, 1H, major), 5.17 (d, 
2
JHH = 15 Hz, 
1H, minor), 3.94-3.88 (overlapping singlets, 3H, minor/major), 2.25-
0.60 (br, 34H), (No B-H peak found). 11B NMR (CD2Cl2): –8.7 
(obscured, minor), 9.11 (d, 1JBH = 85 Hz, major). 
13C{1H} NMR (CDCl3, 
partial, major only): 136.6, 129.0, 128.5, 128.2, 120.6, 119.8, 52.8, 
50.8, 49.94, 44.7, 43.4, 43.0, 42.7, 39.4, 39.1, 37.6, 36.3, 35.3, 33.5, 
33.4, 28.6, 28.5, 23.9, 23.4, 23.4. Anal. Calc. for C31H47BN2: C 81.20, 
H 10.33, N 6.11%. Found: C 80.72, H 10.81, N 6.16%. 
27: Yield: (407 mg , 56% yield). 1H NMR (CDCl3): 7.45-7.40 (bm, 5H), 
6.95 (d, 3JHH = 2 Hz, 1H,), 6.90 (br, 1H), 4.01 (s, 3H) 2.15-1.55 (br, 
10H), 1.15-0.60 (br, 15H), 1.11 (s, 3H), 1.08 (s, 3H), 0.72 (d, 3JHH = 8 
Hz, 3H). 11B NMR (CD2Cl2): δ –9.74 (d, 
1
JBH = 75 Hz). 
13C{1H} NMR 
(CD2Cl2, partial): 140.6, 129.0, 128.8, 128.4, 122.4, 121.2, 51.2, 
50.3, 44.5, 43.7, 43.5, 42.8, 39.6, 39.4, 38.3, 36.4, 35.3, 33.6, 33.3, 
28.7, 28.5, 23.9, 23.8, 23.2, 23.1. Anal. Calc. for C30H45BN2: C 81.06, 
H 10.20, N 6.30%. Found: C 80.63, H 10.66, N 6.22%. 
28: (498 mg, 60% yield). 1H NMR (CD2Cl2): 7.09 (d, 
3
JHH = 2 Hz, 1H), 
6.73 (d, 3JHH = 2 Hz, 1H), 3.87 (s, 6H), 2.41-2.32 (m, 1H), 2.27-2.15 
(m, 1H), 2.11-1.95 (m, 3H), 1.82 (s, 9H), 1.77-1.60 (m, 3H), 1.58-1.48 
(m, 2H), 1.22-1.00 (br, 20H), 0.63 (d, 3JHH = 7 Hz, 3H). 
11B NMR 
(CD2Cl2): –6.85 (d, 
1
JBH = 87 Hz). 
13C{1H} NMR (CDCl3, partial): 119.5, 
118.1, 60.9, 52.0, 50.2, 43.5, 43.2, 43.0, 42.6, 39.7, 39.5, 38.6, 38.6, 
34.1, 32.8, 32.2, 32.2, 28.5, 28.3, 24.7, 24.2, 23.5, 23.4. Anal. Calc. 
for C28H49BN2: C 79.22, H 11.63, N 6.20%. Found: C 78.64, H 11.51, 
N 6.65%. 
Synthesis of rac-9-(1,3-diphenyl-1,2,3-triazol-5-ylidene)-B-H-(10)-
phenyl-9-borabicyclo[3.3.2]decane (29): In a glove box a 4 dram 
vial with a stir bar was charged with lithium-B-H2-(10)-phenyl-9-
borabicyclo[3.3.2]decane49 (62 mg, 0.25 mmol) and THF (2 mL) was 
added. To this solution iodomethane (0.03 mL, 0.5 mmol) was 
added dropwise with stirring and after 1 h reaction at ambient 
temperature the mixture turns a white milky colour. The reaction 
mixture was filtered through a plug of Celite and concentrated in 
vacuo to dryness. To the remaining solid was added 1,3-diphenyl-
1H-1,2,3-triazolium tetrafluoroborate (77 mg, 0.25 mmol) as well as 
a stir bar. The contents of the vial were dissolved in THF (4 mL) and 
a solution of Na[N(SiMe3)2] (46 mg, 0.25 mmol) in THF (1 mL) was 
added dropwise with stirring. The reaction mixture is then capped 
and allowed to stir overnight. The reaction mixture was filtered 
through a syringe filter and all volatiles removed in vacuo. 
Crystallisation from toluene/pentane at –25 °C gave compound 27 
15 mg (0.034 mmol, 13%). 1H NMR (benzene-d6): 7.90 (s, 1H), 7.75 
(m, 2H), 7.42 (m, 2H), 7.31 (t, 3JHH = 8 Hz, 2H), 7.10 (m, 1H), 7.06 – 
6.82 (m, 6H), 6.80 – 6.76 (m, 2H), 3.17 – 2.48 (m, 4H), 2.38 – 2.05 
(m, 11H), 1.94 (m, 1H), 1.47 (m, 1H). 11B NMR (benzene-d6): ̶15.06 
(d, 1JBH = 86 Hz). 
13C NMR (benzene-d6): 172.9, 157.5, 138.0, 135.3, 
130.4, 130.1, 129.8, 129.7, 128.8, 128.4, 128.1,  127.3, 126.1, 123.4, 
121.0, 48.9 (BCHPh), 44.2, 37.8, 36.2, 32.5, 30.9, 28.6, 26.1, 25.3. 
Synthesis of (S)-2-amino-2'-methoxy-1,1'-binaphthalene: From (S)-
2'-methoxy-1,1'-binaphthyl-2-carboxylic acid (5.45 g, 16.6 mmol) as 
described in the literature50 via a Curtius rearrangement. The crude 
product was used directly without any further purification in the 
synthesis of 30. 
Synthesis of (S)-2-azido-2'-methoxy-1,1'-binaphthalene (30). 
Synthesised using a modified literature procedure.51 In a 100 mL 
round bottom flask open to air (S)-2-amino-2'-methoxy-1,1'-
binaphthalene (16.6 mmol) was dissolved in MeCN (60 mL) and 
tert-butylnitrite (90%, 3.3 mL, 24.9 mmol) followed by Me3SiN3 
(94%, 2.8 mL, 20.0 mmol) were added drop-wise with ice-cooling. 
After stirring with ice-cooling for 2 h the mixture was warmed to 
ambient temperature and stirred for 24 h. The precipitate was 
filtered and washed with a minimal amount of MeCN followed by 
copious amounts of pentanes. The title compound was obtained as 
an ochre powder. Yield: 3.36 g (10.31 mmol, 62%). All volatiles 
were removed in vacuo from the mother liquor and another 1.09 g 
(3.34 mmol, 20%) of the title compound was isolated after flash 
column chromatography (silica 10 cm x 4 cm, CH2Cl2/MeOH 50:1). 
Combined yield: 4.44 g, (13.7 mmol, 82%). 1H NMR (CDCl3): 8.06 (d, 
3
JHH = 9 Hz, 1H), 8.03 (d, 
3
JHH = 9 Hz, 1H), 7.93 (d, 
3
JHH = 8 Hz, 2H), 
7.53 (d, 3JHH = 9 Hz, 1H), 7.50 (d, 
3
JHH = 9 Hz, 1H), 7.45 (t, 
3
JHH = 7 Hz, 
1H), 7.38 (t, 3JHH = 7 Hz, 1H), 7.34 – 7.25 (m, 2H), 7.34 – 7.25 (m, 
2H), 7.09 (d, 3JHH = 8 Hz, 1H), 3.83 (s, 3H). 
13C{1H} NMR (CDCl3): 
155.0, 136.0, 134.0, 133.8, 131.2, 130.4, 129.8, 129.1, 128.3, 128.2, 
127.1, 126.9, 126.0, 125.3, 125.0, 124.1, 123.9, 118.7, 117.8, 113.7, 
56.8. HRMS(EI+): (calc.) for C21H15N3O 325.1215, (obs.): 325.1206. 
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Synthesis of (S)-2-(4-(Trimethylsilyl)-1H-1,2,3-triazolyl)-2'-
methoxy-1,1'-binaphthalene, (31): In a glove box a 4-dram vial was 
charged with (S)-2-azido-2'-methoxy-1,1'-binaphthalene (30, 
500 mg, 1.54 mmol) and [Cu(PPh3)Br] (32.0 mg, 0.078 mmol). The 
solids were dissolved in CH2Cl2 (2 mL) and ethynyltrimethylsilane 
(1 mL, 7.08 mmol) was added. The reaction mixture was stirred at 
ambient temperature for 3 weeks. The product was isolated by 
flash column chromatography (silica 20 cm x ø 4 cm, CH2Cl2/MeOH 
100:0 → 100:5). Yield: 589 mg (1.39 mmol, 90%). 1H NMR (CDCl3): 
8.15 (d, 3JHH = 9 Hz, 1H), 8.05 (d, 
3
JHH = 8 Hz, 1H), 8.00 (d, 
3
JHH = 9 Hz, 
1H), 7.99 (d, 3JHH = 9 Hz, 1H), 7.86 (d, 
3
JHH = 8 Hz, 1H.), 7.58 (t, 
3
JHH = 
7 Hz, 1H), 7.26 – 7.44 (m, 5H.), 7.12 (d, 
3
JHH = 8 Hz, 1H), 7.05 (s, 1H), 
3.67 (s, 3H), 0.10 (s, 9H). 13C{1H} NMR (CDCl3): 155.0, 145.0, 134.5, 
133.8, 133.5, 133.1, 130.8, 130.2, 129.5, 128.8, 128.4, 128.3, 128.1, 
127.4, 127.2, 127.1, 126.9, 124.5, 124.0, 123.4, 117.6, 113.0, 56.4, –
1.4. HRMS(EI+): (calc.) for C26H25N3OSi 423.1767, (obs.): 423.1771. 
Synthesis of (S)-2-(1H-1,2,3-triazolyl)-2'-methoxy-1,1'-
binaphthalene, (32): A 50 mL round bottom flask was charged with 
a solution of 31 (1.20 g, 2.83 mmol) in THF (15 mL). A solution of 
TBAF (3.2 mL, 1.0 M in THF, 3.2 mmol) was added dropwise. After 
stirring the reaction mixture at ambient temperature for 2 h H2O 
(30 mL) was added and the aqueous phase was extracted with 
CH2Cl2 (3x). The combined organic phases were washed with 
saturated brine, dried over MgSO4, filtered, and all volatiles were 
removed on a rotary evaporator. The product was obtained as a 
slightly brown solid. The crude product 32 was identified by 
1H NMR spectroscopy and used without further manipulations in 
the next step. 
Synthesis of (S)-1-(2'-Methoxy-1,1'-binaphthyl-2-yl)-3-phenyl-1H-
1,2,3-triazolium tetrafluoroborate, (33): Synthesised following a 
modified published method52 A Schlenk tube was charged with 
crude 32 (855 mg, 2.43 mmol) from the previous reaction, 
diphenyliodonium tetrafluoroborate53 (1.39 g, 3.76 mmol), CuSO4 
(22 mg, 0.138 mmol) in DMF (5 mL) and was stirred at 95 °C for 
16 h. The mixture was cooled to ambient temperature and all 
volatiles removed in vacuo. The resulting oil was subjected to flash-
column chromatography (silica, 4 cm x 8 cm, CH2Cl2/MeOH 100:1 → 
20:1) to give a slightly ochre solid. Yield: 1.121 g (2.17 mmol, 89%). 
1H NMR (CDCl3): 8.87 (s, 1H), 8.51 (s, 1H), 8.23 (d, 
3
JHH = 9 Hz, 1H), 
8.08 (d, 3JHH = 8 Hz, 1H), 8.00 (m, 2H), 7.85 (d, 
3
JHH = 8 Hz, 1H), 7.68 
(t, 3JHH = 8 Hz, 1H), 7.54 – 7.24 (m, 10H), 7.02 (d, 
3
JHH = 8.4 Hz, 1H), 
3.75 (s, 3H). 13C{1H} NMR (CDCl3): 154.7, 134.8, 134.4, 133.5, 132.7, 
132.6, 132.1, 132.0, 131.9, 131.8, 130.6, 130.3, 128.7, 128.6, 128.6, 
128.4, 128.3, 127.7, 127.3, 124.1, 124.1, 121.8, 121.3, 114.7, 112.9, 
56.3. HRMS(EI+): (calc.) for C29H22N3O 428.1757, (obs.) 428.1739. 
Synthesis of (S)-9-(1-(2'-Methoxy-1,1'-binaphthyl-2-yl)-3-phenyl-
1H-1,2,3-triazol-4-yl)-9-borabicyclo[3.3.1]nonane, (34a/b): In a 
glove box a 2 dram vial was charged with triazolium salt 31 
(129.0 mg, 0.25 mmol), Na[N(SiMe3)2] (95% pure, 48.5 mg, 
0.25 mmol), 9-borabicyclo[3.3.1]nonane-dimer (30.5 mg, 
0.125 mmol). At ambient temperature THF (2 mL) was added and 
the reaction mixture was stirred at ambient temperature overnight 
(20 h). 11B NMR spectroscopy of an aliquot in THF confirmed the 
clean formation of the product. The reaction mixture was filtered 
through a syringe filter and all volatiles were removed in vacuo. The 
reminder was taken up in a minimal amount of toluene, layered 
with pentanes, and kept at –25 °C. The supernatant was decanted 
and the solid was washed with pentanes and dried in vacuo to give 
the title compound as ochre an ochre solid. Yield: 114 mg 
(0.207 mmol, 82%). NMR data only for the major isomer 34a 
reported. 1H NMR (CD2Cl2): 8.23 (d, 
3
JHH = 9 Hz, 1H), 8.12 (d, 
3
JHH = 8 
Hz, 1H), 8.05 (d, 3JHH = 9 Hz, 1H), 7.99 – 7.86 (m, 1H), 7.83 (d, 
3
JHH = 
9 Hz, 1H), 7.68 (m, 1H), 7.52 (s, 1H), 7.50 – 7.21 (m, 10H), 7.08 (d, J 
= 9 Hz, 1H), 3.80 (s, 3H), 1.96 – 1.24 (m, 10H), 1.06 (m, 3H), 0.54 (s, 
1H), 0.16 (s, 1H). 11B NMR (CD2Cl2):  ̶  18.4 (d, 
1
JBH = 84 Hz). 
13C{1H} NMR (CD2Cl2): 155.2, 138.3, 134.8, 133.8, 133.4, 133.3, 
132.4, 132.0, 131.8, 130.4, 130.2, 129.3, 128.9, 128.9, 128.7, 128.6, 
128.3, 127.7, 127.5, 125.5, 124.5, 124.4, 122.5, 116.0, 113.1, 56.5, 
36.6, 36.2, 31.6, 31.6, 26.4, 26.0, 22.9. 
General procedure for high pressure hydrogenation: In an inert 
atmosphere glovebox, NHC-borane (0.0261 mmol, 1 equiv.), trityl 
tetrakis(pentafluorophenyl)borate (24 mg, 0.0261 mmol, 1 equiv.) 
and substrate (0.522 mmol, 20 equiv.) were weighed into vials. 
0.4 mL of solvent was used to dissolve the trityl 
tetrakis(pentafluorophenyl)borate and the orange solution was 
transferred to the vial with the NHC-borane, which turns colourless 
upon mixing. The colourless solution was transferred to the vial 
with the substrate with an additional 0.2 mL solvent and equipped 
with a stir bar and placed in a Parr pressure reactor. The reactor 
was sealed, removed from the glovebox, and purged 10 times with 
hydrogen and ultimate pressurised to 102 atm. The reactor was 
stirred magnetically at the specified temperature for the specified 
time and then vented slowly. NMR samples were taken in CDCl3. 
Conversions were determined by 1H NMR spectroscopy from an 
aliquot. The sample was then concentrated in vacuo, dissolved in 
9:1 hexanes:ethyl acetate and passed through a short silica plug. 
The sample was concentrated in vacuo and enantiomeric excess 
was determined by chiral HPLC (Chiralcel OD-H, 98.0 hexanes, 1.0 
isopropanol) with comparison to a racemic sample prepared by 1,3-
dimethylimidazol-2-ylidene-9-borabicyclo[3.3.1]nonane in the 
same hydrogenation process. 
Racemization experiment: In a glove box 9-(1,3-diphenyl-1,2,3-
triazol-5-ylidene)-9-borabicyclo[3.3.1]nonane (21 mg, 0.060 mmol) 
and trityl tetrakis(pentafluorophenyl)borate (55 mg, 0.060 mmol) 
were placed in a vial and dissolved in CD2Cl2 (0.5 mL) generating 
borenium salt 36.40 The resulting solution was transferred to a J. 
Young NMR tube equipped with a Teflon stopper. To this solution 
(+)-bis[(R)-1-phenylethyl]amine (35, 140 µL, 0.612 mmol) was 
added by syringe and the NMR tube was capped and shaken. A 
separate NMR tube was charged with a mixture of B(C6F5)3 (31 mg, 
0.060 mmol) and (+)-bis[(R)-1-phenylethyl]amine (35, 140 µL, 
0.612 mmol) in CD2Cl2 (0.5 mL). The reaction progress was 
monitored by 1H NMR spectroscopy. 
X-ray Diffraction Studies Crystals were coated in paratone oil and 
mounted in a cryo-loop. Data were collected on a Bruker APEX2 X-
ray diffractometer using graphite monochromated Mo-Kα radiation 
(0.71073 Å). The temperature was maintained at 150(2) K using an 
Oxford cryo-stream cooler for both, initial indexing and full data 
collection. Data were collected using Bruker APEX-2 software and 
processed using SHELX and Olex2 an absorption correction applied 
using multi-scan within the APEX-2 program. All structures were 
solved by direct methods within the SHELXTL package54-55 and 
refined with Olex2.56-57 
Results and Discussion 
For the synthesis of our first, camphor-derived borenium ion, 
the commercially available, enantiomerically pure (1R,3S)-
camphoric acid was converted to the corresponding diamine 2 in an 
acid-mediated reaction with sodium azide to give the product in a 
yield of 58% (Scheme 2). Diamine 2 was then transformed into 
carbene precursor 3 in a ring-closing reaction with triethyl 
orthoformate (HC(OEt)3) and ammonium tetrafluoroborate 
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(NH4BF4) in a yield of 79%. Finally, the introduction of R-groups by 
nucleophilic substitution reactions with halogenated alkanes 
affords carbene precursors salts 4-6 in yields ranging from 60 to 
95% (Scheme 2).  
Reaction of the salt 4 with K[N(SiMe3)2] and subsequent 
addition of Piers' borane (HB(C6F5)2) permitted the formation and 
isolation of adduct 7 in 60% yield. Recrystallisation by slow 
evaporation of the solvent afforded crystals suitable for an X-ray 
diffraction study. These data confirmed the structure of 7 (Figure 
2). As expected, the structure shows a pseudo tetrahedral 
geometry at the boron center with a B-CNHC bond distance of 
1.654(2) Å. Subsequent treatment of 7 with trityl 
tetrakis(pentafluorophenyl)borate resulted in hydride abstraction 
from boron and the isolation of the corresponding borenium cation 
8 in 72% yield. 19F NMR resonances are consistent with 
diastereotopic C6F5 rings, and the appearance of 
11B NMR signals at 
-16.7 and 56.0 ppm is consistent with the presence of the anionic 
and cationic boron centres, respectively. Unfortunately, attempts 
to employ 8 in the catalytic hydrogenation of N-benzylidene-tert-
butylamine using a 5 mol% catalyst loading at 25 °C and 4 atm H2 
were unsuccessful. Indeed, analysis of the reaction by NMR 
spectroscopy was consistent with the stoichiometric formation of 7 
and the iminium cation. These data demonstrate that while the FLP 
derived from the borenium cation of 8 and imine effectively split 
H2, the carbene adduct 7 is insufficiently hydridic to deliver hydride 
to the iminium cation, thus inhibiting catalysis. 
 
Scheme 2 Synthesis of 2-17. 
To circumvent this issue, carbene adducts of the weaker Lewis 
acid 9-BBN were targeted. The reaction of the salts 4-6 with 
K[N(SiMe3)2] and 9-BBN affords the corresponding adducts 9-11 
which give rise to 11B NMR signals that are sharp doublets at 
14.2 ppm (1JBH = 83Hz), 14.3 ppm (
1
JBH = 84 Hz) and 12.9 ppm (
1
JBH = 
84 Hz), respectively. These compounds were isolated in yields of 
81% (9), 67% (10) and 63% (11) and gave the expected 1H NMR 
spectra. The structure of 10 was also confirmed by X-ray diffraction 
(Figure 3). The B-CNHC distance is 1.693(5) Å which is significantly 
larger than those seen in NHC-borane adducts (ca. 1.63-1.65 Å).38-39  
By analogy to previous reports,39 reaction of adducts 9-11 with 
trityl tetrakis(pentafluorophenyl)borate gave the corresponding 
borenium cations 12-14, which were isolated in 83-93% yields. 
1H NMR data show the concurrent formation of Ph3CH while the 
11B NMR spectra show signals attributable to the cation as broad 
peaks at 89.1 ppm (12, 13) and 85.8 ppm (14). Crystals of 13 
suitable for X-ray diffraction (Figure 4) revealed an average B-CNHC 
bond length of 1.609(4) Å. This is slightly longer than the analogous 
B-C distances previously described in previously characterized 
borenium cations (1.5768(3) °A,38 1.580(3) Å39).  This may be caused 
by the increase in steric demand of the present carbene relative to 
less demanding NHC ligands. Although the borenium centres in 
compounds 12-14 were expected to be more active than that in 8, 
exposure of a range of imines to 100 bar of H2 at 25 and 110 °C 
gave no reduction. Equimolar reactions of 12-14 with t-Bu3P and H2 
also showed no reactivity at 25 °C, although upon heating to 110 °C 
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for 24 h a slow formation of [HPt-Bu3][B(C6F5)4] in 26% yield was 
observed as evidenced by 31P NMR spectroscopy.107 Interestingly, 
the corresponding 11B NMR spectrum did not show the expected 
formation of the borane adduct but rather a broad signal at 44.0 
ppm. These observations suggest the possibility of a thermal 
rearrangement of the borane adducts 9-11 (Scheme 2). 
 
Figure 2 POV-ray depictions of X-ray structure of 7. H-atoms are omitted for 
clarity. C: black; N: blue; B: yellow-green, F: pink.  
 
 
Figure 3 POV-ray depiction of 10. One of the two molecules in the 
asymmetric unit is shown.) H-atoms have been omitted for clarity. C: black; 
N: blue; B: yellow-green, H: gray. 
To examine this question, compounds 9-11 were allowed to 
stand in solution for 24 h. Each species was observed to react 
further, affording a new signal in the 11B NMR spectra at ca. 44 
ppm. In the case of 9, mild heating at 50 °C for a few hours led to 
complete conversion to compound 15. Interestingly, the analogous 
diethyl-substituted derivative gave 16, only after overnight heating 
whereas the bulkiest adduct 11 was fully converted to 17 upon 
heating to 110 °C overnight. NMR data were consistent with three-
coordinated boron centres in 15-17. An X-ray structure of 17 
(Figure 5) confirmed that this compound results from cleavage of a 
C-N-bond in the carbene and formation of a new B-N-bond with a 
hydride-shift from boron to the carbene carbon atom. This affects 
the net ring expansion of the carbene by the B-C link originating 
from the 9-BBN framework. The C-B-bonds were found to average 
1.581(3) Å, which is significantly shorter than the carbene C-B-bond 
in the precursor adduct. The newly formed B-N-bonds average 
1.401(3) Å in the two molecules in the asymmetric unit. These are 
considerably shorter than typical B-N bonds.58 It is interesting to 
note that a single diastereomer of 17 was obtained demonstrating 
that the ring exapansion is stereoselective, presumably a result of 
the existing chiral centers in the carbene in 11 en route to 17.   
 
 
Figure 4 POV-ray depictions of the cation of 13 (one of the two molecules in 
the asymmetric unit is shown). H-atoms and the anion are omitted for 
clarity. C: black; N: blue; B: yellow-green.  
 
 
Figure 5 POV-ray depiction of 17, one of the molecules in the asymmetric 
unit is shown. C: black; N: blue; B: yellow-green, H: gray. H-atoms, except 
those on chiral carbons are omitted for clarity.  
The formation of 15-17 suggests that thermal degradation is a 
significant factor in explaining the inability of 9-11 to act as the 
Lewis acid component of an FLP in the activation of dihydrogen. 
While activation of hydrogen may proceed to some extent, ring-expansion 
may out-compete hydride delivery and thus inhibit catalytic activity. 
Alternatively, the substituents on the carbene may act to sterically 
inhibit access to the vacant p-orbital on boron. This latter view is 
also consistent with the well-known increase in steric demands 
resulting from the expanded NCN-angle in carbene ligands in 9-11 
compared to those seen in the imidazole-based NHC analogues.  
In an effort to circumvent the steric demands in the above 
borenium cations, a second group of chiral borane adducts were 
selected. In this case, fused oxazole rings were employed to deter 
ring expansion and hopefully provide viable borenium catalysts for 
FLP hydrogenations. The triflate salts 18 and 19 were prepared by 
literature methods. Reaction of the former species with 9-BBN, BH3 
and Cy2BCl afforded the anticipated carbene adducts 20-22 
(Scheme 3). In a similar fashion, reaction of the tert-butyl-
substituted ligand 19 and 9-BBN afforded adduct 23. The 
spectroscopic data were as expected. The 11B NMR signals of 20 
and 23 were found to be similar, appearing at -16.9 and -16.4 ppm 
as doublets with 1JBH of 83 and 86 Hz, respectively. These 
resonances are consistent with four coordinate boron centers and 
thus are consistent with the formation of 20-23 as chiral carbene 
adducts. It is noteworthy that compounds 20, 21 and 23 have been 
exploited by Lindsay and McArthur as reagents for the 
stoichiometric, enantioselective reduction of ketones.59 
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N
N
O
O
R
R
N
N
O
O
R
R
B
H
[O3SCF3]
R = i-Pr 18, t-Bu 19
9-BBN
K[N(SiMe3)2]
R = i-Pr 20, t-Bu 23
N
N
O
O
i-Pr
i-Pr
BH3
21
K[N(SiMe3)2]Me2SBH3
n-BuLi
Cy2BCl
N
N
O
O
i-Pr
i-Pr
B
22
Cy
Cy
Cl
Scheme 3 Synthesis of 20-23. 
 
Figure 6 POV-ray depiction of 20, C: black; N: blue; B: yellow-green; O: red, 
H: gray. H-atoms except the BH are omitted for clarity. 
 
 
Figure 7 POV-ray depiction of 21, C: black; N: blue; B: yellow-green; O: red., 
H: gray. H-atoms except the BH are omitted for clarity. 
                                           
 
 
 
 
 
 
 
Figure 8 POV-ray depiction of 22, C: black; N: blue; B: yellow-green; O: red, 
Cl: green, H: gray.. H-atoms are omitted for clarity. 
      The structures of these compounds were subsequently 
confirmed with crystallographic studies (Figures 6-9). The 
corresponding B-Ccarbene bond distances in 20-23 were found to be 
1.610(3) Å, 1.593(2) Å, 1.647(2) Å and 1.641(2) Å, respectively. 
These data reflect the steric impact of the substituents at the boron 
centre. The shortest B-C bond distance is seen for the borane 
adduct 21, while the longest of these four derivatives occurs for the 
Cy2BCl derivative 22. Comparing the difference between 20 and 23 
indicates that steric conflict between the t-butyl substituents and 
the 9-BBN fragment results in a slight lengthening of the B-C bond.   
 
Figure 9 POV-ray depiction of 23, C: black; N: blue; B: yellow-green; O: red, 
H: gray.. H-atoms except the BH are omitted for clarity.   
Chiral borenium cations derived from chiral boranes were also 
prepared. To this end, (+)-diisopinocampheylborane (Ipc2BH) which 
is accessible from the hydroboration of α-pinene, was combined 
with the carbenes 1,3-dimethylimidazol-2-ylidene and 1,3-di-iso-
propylimidazol-2-ylidene to give 24 and 25 which could be isolated 
in 34% and 37% yield, respectively (Scheme 3). Similarly, reactions 
of unsymmetrically substituted NHCs 1-benzyl-3-methylimidazol-2-
ylidene, 1-methyl-3-phenylimidazol-2-ylidene and 1-tert-butyl-3-
methylimidazol-2-ylidene with Ipc2BH gave the corresponding 
adducts 26-28 in 83%, 56% and 60% yield, respectively (Scheme 4). 
11B NMR spectra of each of these products show doublet 
resonances ranging from –6.8 to 9.7 ppm with B-H coupling 
constants of 77-86 Hz. Interestingly, 26 degrades in chloroform, 
presumably a result of the steric conflict between the NHC and 
isopinocampheyl groups. Crystals suitable for X-ray diffraction 
crystallography could be obtained for 24, 26 and 27 (Figures 10-12). 
These data confirmed the formulations and the expected 
pseudotetrahedral geometry about boron. In the solid-state, B-CNHC 
bond lengths are 1.638(2) Å, 1.648(4) Å and 1.636(2) Å for 24, 26 
and 27, respectively. 
 
N N R'R
THF, r.t., 24 h
-KX
K[N(SiMe3)2]
X-
N
N
R'
R
BH BH
R = R' = Me 24, i -Pr 25,
R = Me, R' = Bn 26, Ph 27, t -Bu 28  
Scheme 4 Synthesis of 24-28. 
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Figure 10 POV-ray depiction of 24. C: black; N: blue; B: yellow-green; O: red, 
H: gray.. H-atoms except the BH are omitted for clarity. 
 
Figure 11 POV-ray depiction of 26. C: black; N: blue; B: yellow-green; O: red, 
H: gray. H-atoms except the BH are omitted for clarity. 
 
Figure 12 POV-ray depiction of 27. C: black; N: blue; B: yellow-green; O: red, 
H: gray.. H-atoms except the BH are omitted for clarity. 
 
Triazolium-based carbene adducts of chiral boranes developed 
by Soderquist were also investigated49 as we speculated that the 
C1-  
B H
Ph
H
Li
N
N N PhPh
B H
Ph
MeI, THF
Na[N(SiMe3)2].
N
N N PhPh
BF4
rac-29, 13%
rac
 
Scheme 5 Synthesis of meso-ionic carbene 9-BBD adduct rac-29. 
 
NH2
OMe
N
OMe
N
N
SiMe3
N
OMe
N
N
N
OMe
N
N Ph
N
OMe
N
N Ph
BH
BF4
N3
OMe
tBuONO
TMSN3
MeCN
0 °C → r.t., 24 h
5 mol% [Cu(PPh3)Br]
CH2Cl2, r.t., 3 weeks
TMS
[Bu4N]F
THF, r.t., 2 h
[Ph2I][BF4]
5 mol% CuSO4
DMF, 95 °C, 16 h
Na[N(SiMe3)2]
0.5 (9BBN)2
N
OMe
N
N Ph
HB
+
34a : 34b, 82%
10 : 1
30, 82%
31, 90%32
33, 89%
THF, r.t., 20 h
 
Scheme 6 Synthesis of axial chiral carbene borane 34. 
symmetric environment about boron might improve selectivities in 
catalytic hydrogenations. To this end, lithium-B-H2-(10)-phenyl-9-
borabicyclo [3.3.2]decane was prepared however formation of the 
carbene adduct of the corresponding neutral borane (29) was 
isolated in low yield (Scheme 5). Presumably these difficulties are 
caused by the steric demands of both components. This view was 
consistent with the observation that use of the more hindered 
1,3,4-triphenyl-1H-1,2,3-triazolium tetrafluoroborate failed to give 
an adduct. Furthermore, when rac-29 precatalyst was activated by 
[Ph3C][B(C6F5)4] in the hydrogenation of N-benzylidene tert-
butylamine at elevated H2 pressure, no hydrogenation was seen, 
further indicating that excessive steric hindrance impedes effective 
hydride delivery even to otherwise reactive substrates.  
An alternative strategy based on triazolium derivatives, was 
based on use of a chiral triazolium derivatives. To this end, the 
known (S)-2-amino-2'-methoxy-1,1'-binaphthalene50 was reacted 
with tert-butylnitrite and trimetylsilyl azide to give the 
corresponding binaphthyl azide 30 in 82% yield. While sluggish, the 
Cu-catalysed Huisgen cyclo-addition of 31 with 
ethynyltrimethylsilane was achieved in 90% yield of 32 using 
[Cu(PPh3)Br] as the catalyst. Following deprotection, 32 was 
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arylated to give the 1,2,3-triazolium tetrafluoroborate 33 in 89% 
yield. Subsequent reaction with Na[N(SiMe3)2] and 0.5 equivalents 
of (9-BBN)2 gave a 10:1 mixture of the two regio-isomeric carbene 
boranes 34a/b which was isolated in 82% combined yield (scheme 
6).  
 
Table 1 Hydrogenations of Imines by catalysts derived from 20, 21,23-28 and 34 
 
Entry 
 
Pre-catalyst t (h) T(°C) Yield (%) ee 
1 20 24 25 100 7 
2 20 6 25 88 9 
3 20 3 25 50 12 
4 20 12 0  94 1 
5 20 3 50 71 8 
6 21 24 25 3 5 
7 21 3 50 6 7 
8 23 24 25 0 - 
9 23 48 25 0 - 
10 24 4 25 55 12 
11 24 24 -30 5 20 
12 24a 24 25 0 - 
13 24b 24 25 12 15 
14 25 24 -30 <5 8 
15 26 4 25 47 13 
16 26 24 -30 5 13 
17 27 20 -30 <5 - 
18 28 4 25 0 - 
19 28 20 -30 0 - 
20 34 18 25 100 6 
a toluene; b chlorobenzene , all other catalysis done in CH2Cl2. Yield determined by 
1H NMR spectroscopy. b Enantiomeric excess determined by chiral HPLC. 
The potential of 20, 21, and 23 to act as precursors for 
borenium cation-based catalysts was probed via, a protocol in 
which the borane precursors were treated with trityl 
tetrakis(pentafluorophenyl)borate in CH2Cl2 and the in situ catalyst 
(5 mol%) was exposed to a solution of the prochiral imine substrate 
Ph(Me)C=NPh and pressurised under 102 atm of H2. Following the 
reaction, the conversion and products were characterised by NMR 
spectroscopy and by chiral HPLC. Interestingly, 21 and 23 are 
inactive giving 6% reduction at best even upon heating to 50 °C. In 
contrast, compound 20 serves as a competent catalyst precursor, 
affording effective imine reduction after 24 h at temperatures 
ranging from 0-50 °C. However, in all cases, the enantioselectivity 
for the ketamine reduction is low, ranging from 1-12% ee (Table 1). 
In a similar trial, reduction of MeOC6H4(Me)C=NPh using the 
catalyst precursor 20 occurred after 18 h giving the product in 91% 
yield with 11% ee. In contrast, Ph(Me)C=NCH2Ph as well as the 
ketones Et2CO and PhMeCO resulted in no reaction at all (See SI). 
Similarly catalytic studies of 24-28 and 34 these systems, the 5 
mol% catalyst loading resulted in no catalytic activity being 
observed for 28 and only trace conversion of N-(1-
phenylethylidene)aniline to N-phenyl-1-phenylethylamine was 
observed using 27 by 1H-NMR spectroscopy after 4 h of reaction 
under 102 atm hydrogen. Compounds 24 and 26 gave conversions 
of 55% and 47%, respectively, reflecting the observation that high 
steric demands inhibit hydrogenation catalysis for NHC-stabilised 
borenium catalysts. Hydrogenation products of 24 and 26 showed 
enantiomeric excesses of 12% and 13%, respectively. Reduced 
temperature (-30 °C) hydrogenation under the similar conditions 
for 20 hours severely diminished conversion and offered only a 
modest improvement in stereoselectivity (22% ee). Under these 
latter conditions, 25 showed limited conversion and an 
enantioselectivity of only 8%. (Table 1). While the two isomers of 
34 could not be separated by crystallisation and were therefore 
subsequently tested in hydrogenations as mixtures. At 10 mol% 
catalyst loading and 90 atm H2 pressure in CH2Cl2, full conversion to 
the corresponding amine was observed after less than 18 h reaction 
time. However, the product was obtained in only 6% ee. 
While in some cases, the above borenium-based hydrogenation 
catalysts were effective for reduction of ketamines, in general, poor 
enantioelectivities were seen. In an effort to understand this we 
speculated that the delivery of the hydride to the prochiral carbon, 
maybe reversible leading to epimerisation of the resulting chiral 
amine. To probe this question, the chiral, enantiopure secondary 
amine (+)-bis[(R)-1-phenylethyl]amine (35) was exposed to a 
catalytic amount of the previously reported achiral MIC-borenium 
ion 36.40 While at ambient temperature, only trace amounts of 
meso-35 were detected by 1H NMR spectroscopy after 16 h, a 
significant degree of epimerisation was seen after 42 h at 65 °C.  
This stands in contrast, to the more rapid epimerisation of 35 with 
B(C6F5)
60 and supports the view it should be possible to exploit that 
borenium cations for asymmetric reductions.      
Conclusions 
In conclusion, exploiting both NHC and triazolium-based 
carbenes, we have reported the synthesis of a number of novel 
chiral carbene-borane adducts in which chirality is located either on 
the carbene or alternatively on the borane. While some of these 
species are effective precursors for imine reduction in 
hydrogenation catalysis, in general these systems exhibit poor 
enantioselectivity. Species substituted with C6F5 groups on boron 
preclude effective hydride delivery, while for 9-BBN and 9-BBD 
derivatives steric demands appear to be problematic under mild 
conditions. In some cases, elevated temperatures were shown to 
afford a thermally induced ring-expansion resulting from C-N bond 
cleavage in the carbene. Bisoxazoline-derived NHC borenium 
cations, the analogous axially chiral triazolium-borenium 
derivatives as well as borenium cations derived from the chiral 
borane, Ipc2BH, provide active hydrogenation catalysts however 
these systems provided limited stereoselectivity. Nonetheless, the 
low selectivities observed for these chiral borenium cation catalysts 
are not caused by selectivity erosion by epimerisation of the chiral 
product. This supports the notion that further catalyst design 
considerations may be fruitful. Our efforts to this end will be 
reported in due course.  
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